Jim Simons’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $164K | Buy |
+101,253
| New | +$208K | ﹤0.01% | 2949 |
|
|
2025
Q4 | – | Sell |
-101,800
| Closed | -$210K | – | 3311 |
|
|
2025
Q3 | $210K | Sell |
101,800
-27,890
| -22% | -$77.1K | ﹤0.01% | 3119 |
|
|
2025
Q2 | $409K | Buy |
+129,690
| New | +$396K | ﹤0.01% | 2933 |
|
|
2025
Q1 | – | Sell |
-483,090
| Closed | -$2.1M | – | 3520 |
|
|
2024
Q4 | $2.1M | Sell |
483,090
-119,294
| -20% | -$373K | ﹤0.01% | 2020 |
|
|
2024
Q3 | $1.61M | Buy |
602,384
+444,894
| +282% | +$1.05M | ﹤0.01% | 2160 |
|
|
2024
Q2 | $350K | Buy |
157,490
+71,390
| +83% | +$269K | ﹤0.01% | 2853 |
|
|
2024
Q1 | $460K | Sell |
86,100
-30,300
| -26% | -$80.5K | ﹤0.01% | 2899 |
|
|
2023
Q4 | $172K | Sell |
116,400
-37,600
| -24% | -$45.5K | ﹤0.01% | 3182 |
|
|
2023
Q3 | $214K | Sell |
154,000
-157,290
| -51% | -$265K | ﹤0.01% | 3068 |
|
|
2023
Q2 | $458K | Sell |
311,290
-20,018
| -6% | -$32.3K | ﹤0.01% | 2917 |
|
|
2023
Q1 | $547K | Sell |
331,308
-159,682
| -33% | -$274K | ﹤0.01% | 2834 |
|
|
2022
Q4 | $687K | Buy |
490,990
+69,002
| +16% | +$98.8K | ﹤0.01% | 2751 |
|
|
2022
Q3 | $650K | Sell |
421,988
-305,628
| -42% | -$736K | ﹤0.01% | 2756 |
|
|
2022
Q2 | $1.6M | Buy |
727,616
+236,158
| +48% | +$396K | ﹤0.01% | 2359 |
|
|
2022
Q1 | $1.22M | Buy |
+491,458
| New | +$1.74M | ﹤0.01% | 2596 |
|
|
2020
Q3 | – | Sell |
-268,800
| Closed | -$1.35M | – | 3415 |
|
|
2020
Q2 | $1.35M | Buy |
268,800
+129,091
| +92% | +$264K | ﹤0.01% | 2402 |
|
|
2020
Q1 | $141K | Sell |
139,709
-177,594
| -56% | -$251K | ﹤0.01% | 3168 |
|
|
2019
Q4 | $393K | Buy |
317,303
+7,700
| +2% | +$11K | ﹤0.01% | 2980 |
|
|
2019
Q3 | $468K | Buy |
309,603
+60,482
| +24% | +$118K | ﹤0.01% | 2891 |
|
|
2019
Q2 | $623K | Buy |
249,121
+88,900
| +55% | +$285K | ﹤0.01% | 2908 |
|
|
2019
Q1 | $601K | Buy |
160,221
+45,755
| +40% | +$164K | ﹤0.01% | 2867 |
|
|
2018
Q4 | $361K | Buy |
114,466
+15,032
| +15% | +$68.5K | ﹤0.01% | 2975 |
|
|
2018
Q3 | $486K | Buy |
99,434
+65,467
| +193% | +$310K | ﹤0.01% | 2855 |
|
|
2018
Q2 | $157K | Buy |
33,967
+32,180
| +1,801% | +$538K | ﹤0.01% | 3103 |
|
|
2018
Q1 | $45K | Buy |
+1,787
| New | +$44.1K | ﹤0.01% | 3306 |
|
|
2017
Q2 | – | Sell |
-405
| Closed | -$33K | – | 3207 |
|
|
2017
Q1 | $33K | Buy |
+405
| New | +$55K | ﹤0.01% | 3163 |
|
|
2015
Q3 | – | Sell |
-1,835
| Closed | -$1.34M | – | 3187 |
|
|
2015
Q2 | $1.34M | Buy |
+1,835
| New | +$1.3M | ﹤0.01% | 2297 |
|
Other funds holding CRDF
VCM
LCM
P
ACA
FLPIM
Jim Simons's CRDF Position: Q1 2026 in Review
Jim Simons opened a new position in Cardiff Oncology (CRDF) in Q1 2026: 101,253 shares worth $164K. The stake represents ﹤0.01% of the portfolio and ranks #2949 among its holdings. This is a return to the name: Jim Simons previously reported a position in CRDF as recently as Q3 2025.
Jim Simons first reported a position in CRDF in Q2 2015 and has held it in 27 quarters since. The position peaked at $2.1M in Q4 2024. 117 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.
- Jim Simons held 101,253 shares of Cardiff Oncology worth $164K as of Q1 2026.
- Cardiff Oncology was a new Jim Simons position in Q1 2026.
- Cardiff Oncology made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2949 holding.
- Jim Simons first reported a position in Cardiff Oncology in Q2 2015 and has held it in 27 quarters since.
- Jim Simons's Cardiff Oncology position peaked at $2.1M in Q4 2024.
- 117 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.